ArticleFrontiers in medicine2025
Construction and validation of a risk assessment scale for multidrug-resistant bacteria infections in critically ill patients.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: To develop a risk assessment scale for infections caused by multidrug-resistant organisms (MDROs) in patients with critical illness and to evaluate its reliability and validity. Methods: An initial risk assessment scale for MDRO infections in patients with critical illness was developed by using a systematic literature review, the Delphi method, and the analytic hierarchy process. Data from 750 critically ill patients admitted to the intensive care unit (ICU) of a Grade A tertiary hospital in China between January 2019 and June 2025 were analyzed. The scale's reliability and validity were assessed through exploratory factor analysis ( Results: The risk assessment scale for MDRO infection in patients with critical illness comprised five dimensions and 20 items. The Cronbach's alpha for the total scale was 0.873. The scale-level content validity index was 0.925, with the content validity indices for individual scale items ranging 0.875-1.000. Exploratory factor analysis enabled the extraction of five common factors, which accounted for 67.861% of the cumulative variance. Confirmatory factor analysis yielded Conclusion: The risk assessment scale for MDRO infection in patients with critical illness demonstrated good reliability and validity, enabling the scientific and reliable assessment of patient infection risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.